- Report
- January 2026
- 180 Pages
Global
From €3941EUR$4,500USD£3,421GBP
- Report
- February 2026
- 465 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- September 2025
- 270 Pages
Global
From €4375EUR$4,995USD£3,797GBP
- Report
- January 2026
- 189 Pages
Global
From €3450EUR$3,939USD£2,994GBP
- Report
- April 2025
- 200 Pages
Global
From €3932EUR$4,490USD£3,413GBP
- Report
- July 2023
- 200 Pages
Global
From €4073EUR$4,650USD£3,535GBP
- Report
- October 2023
- 120 Pages
Global
From €5211EUR$5,950USD£4,523GBP
- Report
- October 2023
- 117 Pages
Global
From €3941EUR$4,500USD£3,421GBP
- Report
- March 2024
- 132 Pages
Global
From €832EUR$950USD£722GBP
- Report
- November 2021
- 527 Pages
Global
From €3503EUR$4,000USD£3,041GBP
The miRNA Sequencing market is a subset of the larger genomics market. It is focused on the sequencing of microRNAs, which are small, non-coding RNA molecules that regulate gene expression. miRNA sequencing is used to identify and quantify miRNAs in a sample, and can be used to study gene expression, disease diagnosis, and drug development.
miRNA sequencing is a rapidly growing field, with a variety of companies offering services and products. These include Illumina, Thermo Fisher Scientific, Agilent Technologies, Bio-Rad Laboratories, and QIAGEN. Show Less Read more